PIERINI, ANTONIO
 Distribuzione geografica
Continente #
NA - Nord America 2.500
AS - Asia 2.009
EU - Europa 1.757
SA - Sud America 404
AF - Africa 55
OC - Oceania 4
Totale 6.729
Nazione #
US - Stati Uniti d'America 2.443
SG - Singapore 967
IT - Italia 486
CN - Cina 337
BR - Brasile 307
IE - Irlanda 294
RU - Federazione Russa 247
HK - Hong Kong 231
VN - Vietnam 158
FR - Francia 136
DE - Germania 132
FI - Finlandia 110
KR - Corea 74
GB - Regno Unito 63
SE - Svezia 57
IN - India 52
UA - Ucraina 50
AT - Austria 46
BD - Bangladesh 33
TR - Turchia 31
AR - Argentina 29
PL - Polonia 25
MX - Messico 24
NL - Olanda 22
CA - Canada 21
EC - Ecuador 21
CZ - Repubblica Ceca 19
IQ - Iraq 18
PK - Pakistan 17
ZA - Sudafrica 16
SA - Arabia Saudita 14
BE - Belgio 13
CH - Svizzera 13
CO - Colombia 13
ID - Indonesia 11
JP - Giappone 11
VE - Venezuela 10
PH - Filippine 9
MA - Marocco 8
RO - Romania 8
MY - Malesia 7
CL - Cile 6
KE - Kenya 6
LT - Lituania 6
PE - Perù 6
ES - Italia 5
ET - Etiopia 5
IL - Israele 5
JO - Giordania 5
PT - Portogallo 5
UZ - Uzbekistan 5
NP - Nepal 4
AO - Angola 3
AU - Australia 3
BA - Bosnia-Erzegovina 3
BG - Bulgaria 3
BO - Bolivia 3
DK - Danimarca 3
DZ - Algeria 3
GR - Grecia 3
HN - Honduras 3
LA - Repubblica Popolare Democratica del Laos 3
LB - Libano 3
NI - Nicaragua 3
OM - Oman 3
PY - Paraguay 3
TN - Tunisia 3
UY - Uruguay 3
EG - Egitto 2
GF - Guiana Francese 2
HR - Croazia 2
KG - Kirghizistan 2
NG - Nigeria 2
TT - Trinidad e Tobago 2
AE - Emirati Arabi Uniti 1
AL - Albania 1
AZ - Azerbaigian 1
BH - Bahrain 1
CM - Camerun 1
DJ - Gibuti 1
DM - Dominica 1
GD - Grenada 1
GE - Georgia 1
GY - Guiana 1
IM - Isola di Man 1
JM - Giamaica 1
KI - Kiribati 1
LV - Lettonia 1
ML - Mali 1
MM - Myanmar 1
MN - Mongolia 1
MR - Mauritania 1
MU - Mauritius 1
PA - Panama 1
RS - Serbia 1
SC - Seychelles 1
SI - Slovenia 1
SK - Slovacchia (Repubblica Slovacca) 1
TH - Thailandia 1
TL - Timor Orientale 1
Totale 6.727
Città #
Singapore 719
Dublin 294
San Jose 256
Chandler 253
San Mateo 240
Hong Kong 227
Ashburn 191
Perugia 182
Boardman 165
Santa Clara 111
Moscow 97
Beijing 76
Lauterbourg 76
Altamura 75
Seoul 74
Munich 64
Andover 60
Los Angeles 60
Medford 59
Princeton 58
Lawrence 55
Wilmington 53
Turku 51
Hanoi 45
Ho Chi Minh City 45
New York 40
Ann Arbor 38
Vienna 36
The Dalles 30
Piscataway 29
São Paulo 27
Helsinki 26
Frankfurt am Main 25
Rome 23
Des Moines 22
Redmond 20
San Paolo di Civitate 20
Bologna 19
Nuremberg 19
Council Bluffs 17
Jacksonville 17
London 17
Warsaw 16
Hefei 15
Houston 15
Norwalk 15
Brooklyn 14
Milan 14
Dearborn 13
Denver 13
Falls Church 13
Orem 13
Rio de Janeiro 13
Brno 12
Brussels 12
Florence 12
Johannesburg 12
Atlanta 11
Dallas 11
Phoenix 11
Saint Petersburg 11
Amsterdam 10
Boston 10
Chicago 10
Quito 10
Stockholm 10
Tokyo 10
Hải Dương 9
Lappeenranta 9
Terni 9
Baghdad 8
Groningen 8
Guangzhou 8
Redwood City 8
West Jordan 8
Bucharest 7
Da Nang 7
Falkenstein 7
Izmir 7
Manchester 7
Poplar 7
Riyadh 7
Chennai 6
Foligno 6
Montreal 6
Nairobi 6
Padova 6
San Francisco 6
Secaucus 6
Ancona 5
Brasília 5
Kocaeli 5
Lima 5
Marsciano 5
Medellín 5
Mexico City 5
Mumbai 5
Seattle 5
Shanghai 5
Toronto 5
Totale 4.530
Nome #
NOTCH1 inhibition prevents GvHD and maintains GvL effect in murine models 143
Dectin-1 Y238X polymorphism associates with susceptibility to invasive aspergillosis in hematopoietic transplantation through impairment of both recipient- and donor-dependent mechanisms of antifungal immunity. 133
"Designed" grafts for HLA-haploidentical stem cell transplantation. 123
TNFR2 signaling modulates immunity after allogeneic hematopoietic cell transplantation 120
The NOTCH1/CD39 axis: A Treg trip-switch for GvHD 119
Clinical-Grade Expanded Regulatory T Cells Prevent Graft-versus-Host Disease While Allowing a Powerful T Cell Dependent Graft-versus-Leukemia Effect in Murine Models 119
Haploidentical hematopoietic transplantation from KIR ligand-mismatched donors with activating KIRs reduces nonrelapse mortality 118
Haploidentical age-adapted myeloablative transplant and regulatory and effector T cells for acute myeloid leukemia 115
Enhancing Regulatory T Cell Function and Homing to the Gut to Improve graft-versus-host Disease Prevention after Adoptive Transfer in Allogeneic Hematopoietic Transplantation 114
CMV management with specific immunoglobulins: A multicentric retrospective analysis on 92 allotransplanted patients 113
CD4+FOXP3+ Regulatory T Cell Therapies in HLA Haploidentical Hematopoietic Transplantation 113
Activation of Regulatory T Cells with IL-2 and TNF-alpha to Promote Homing to the Gut and to Improve Acute GvHD Prevention 110
T regulatory cell separation for clinical application. 109
Clinical-Grade Expanded Regulatory T Cells Are Enriched with Highly Suppressive Cells Producing IL-10, Granzyme B, and IL-35 106
HLA-haploidentical transplantation with regulatory and conventional T-cell adoptive immunotherapy prevents acute leukemia relapse 105
Tregs prevent GVHD and promote immune reconstitution in HLA-haploidentical transplantation. 104
Multi-institutional evaluation of MVCT guided patient registration and dosimetric precision in total marrow irradiation: A global health initiative by the international consortium of total marrow irradiation 104
Genetically-determined hyperfunction of the S100B/RAGE axis is a risk factor for aspergillosis in stem cell transplant recipients 101
Acute myeloid leukemia development soon after anti-CD19 chimeric antigen receptor T-cell infusion in a patient with refractory diffuse large B-cell lymphoma and pre-existing clonal hematopoiesis 100
HLA-MATCHED TREG/TCON ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTATION ENSURES REMARKABLE CHRONIC GVHD/LEUKEMIA FREE SURVIVAL IN HIGH-RISK LEUKEMIA PATIENTS 100
T cell depletion and no post transplant immune suppression allow separation of graft versus leukemia from graft versus host disease 97
ADOPTIVE IMMUNOTHERAPY WITH REGULATORY AND CONVENTIONAL T CELLS AFFORDS HIGH RATE OF CHRONIC GVHD/RELAPSE-FREE SURVIVAL IN ACUTE MYELOID LEUKEMIA AFTER MYELOABLATIVE HAPLOIDENTICAL TRANSPLANTATION 96
HLA-haploidentical transplantation with regulatory and conventional T-cell adoptive immunotherapy prevents acute leukemia relapse 96
How Adoptive Immunotherapy with Conventional T and Regulatory T Cells Exerts a Gvl Effect without GvHD, after Haploidentical Hematopoietic Transplantation 96
T cells expressing chimeric antigen receptor promote immune tolerance 93
Acute GvHD after HLA- Haploidentical Hematopoietic Cell Transplantation with Regulatory and Conventional T Cell Immunotherapy Does Not Adversely Affect Transplantation Outcomes 92
The effect of TNF-α on regulatory T cell function in graft-versus-host disease 92
TLR3 essentially promotes protective class I-restricted memory CD8+ T-cell responses to Aspergillus fumigatus in hematopoietic transplanted patients. 91
Case Report: Subtotal Lymphoid and Total Marrow Irradiation as Bridge Therapy to CD19-Directed CAR T Cells in a Chemorefractory DLBCL With Leukemic Involvement 90
REGULATORY T CELL ADOPTIVE IMMUNOTHERAPY PROMOTES B CELL IMMUNITY AFTER HAPLOIDENTICAL TRANSPLANTATION 88
Haploidentical hematopoietic transplantation from KIR ligand-mismatched donors with activating KIRs reduces non-relapse mortality 88
CD41 invariant natural killer T cells protect from murine GVHD lethality through expansion of donor CD41CD251FoxP31 regulatory T cells 87
A pro-inflammatory environment in bone marrow of Treg transplanted patients matches with graft-versus-leukemia effect 86
New mechanism of lymphoma-induced bone marrow aplasia 86
Foxp3+regulatory T cells maintain the bone marrow microenvironment for B cell lymphopoiesis 85
Blinatumomab Redirects Donor Lymphocytes against CD19+ Acute Lymphoblastic Leukemia without Relevant Bystander Alloreactivity after Haploidentical Hematopoietic Stem Cell Transplantation 84
The “ultimate” haploidentical transplantation for the elderly with high-risk acute myeloid leukemia 83
The Leukemic Isocitrate Dehydrogenase (IDH) 1/2 Mutations Impair Myeloid and Erythroid Cell Differentiation of Primary Human Hematopoietic Stem and Progenitor Cells (HSPCs) 81
Regulatory T cells and natural killer T cells for modulation of GVHD following allogeneic hematopoietic cell transplantation 80
Donor Requirements for Regulatory T Cell Suppression of Murine Graft-versus-Host Disease 80
NK cell reconstitution is improved during allogeneic hematopoietic stem cell transplantation by infusion of NK cell-committed progenitor cells (HEM5P. 233) 78
Regulation of murine NK cell exhaustion through the activation of the DNA damage repair pathway 77
FISH analysis reveals frequent co-occurrence of 4q24/TET2 and 5q and/or 7q deletions. 76
HLA-Matched Treg/Tcon Allogeneic Hematopoietic Cell Transplantation Is Safe and Ensures Remarkable Chronic GvHD/Leukemia Free Survival in High-Risk Leukemia Patients 73
Chronic stimulation results in NK cell function impairment mediated by NKG2D 73
Control of alloreactivity using transient expression of a monoclonal antibody directed chimeric antigen receptor in conventional and regulatory T cells 72
HAPLOIDENTICAL TRANSPLANTATION WITH TREG-TCON ADOPTIVE IMMUNOTHERAPY FOR THE CURE OF ACUTE MYELOID LEUKEMIA WITH HIGH-RISK CYTOGENETICS 71
Rifaximin use favoured micafungin-resistant Candida spp. infections in recipients of allogeneic hematopoietic cell transplantation 71
Engraftment of Embryonic Stem Cells and Differentiated Progeny by Host Conditioning with Total Lymphoid Irradiation and Regulatory T Cells 70
Impact of Donor T Cells on NK Cell Development after Allogeneic Hematopoietic Cell Transplantation 70
The Evolution of T Cell Depleted Haploidentical Transplantation 70
CD4+FoxP3+ Regulatory T Cells Promote B Cell Differentiation and Induce Tolerance to Bone Marrow Grafts 69
Mutational analisys of JAK2 VAL617PHE in a new series of chronic myelomonocytic leukemia and related atypical myeloproliferative disorders 68
DR3 signaling modulates the function of Foxp3+regulatory T cells and the severity of acute graft-versus-host disease 68
Regulatory T Cell Adoptive Immunotherapy Promotes B Cell Immunity after Haploidentical Transplantation 66
Novel Immune Cell-Based Therapies to Eradicate High-Risk Acute Myeloid Leukemia 66
HLA-haploidentical hematopoietic stem cells transplantation with regulatory and conventional T-cell adoptive immunotherapy in pediatric patients with very high-risk acute leukemia 66
CD4+FoxP3+Regulatory T Cells Regulate B Cell Differentiation and Induce Tolerance to Bone Marrow Grafts 65
Treatment with agonistic DR3 antibody results in expansion of donor Tregs and reduced graft-versus-host disease 64
Impact of total marrow/lymphoid irradiation dose to the intestine on graft-versus-host disease in allogeneic hematopoietic stem cell transplantation for hematologic malignancies 63
NPM1 monoallelic deletion in a subgroup of MDS/AML with del(5q) or monosomy 5 and complex karyotype 63
Feasibility of a Novel Sparse Orthogonal Collimator–Based Preclinical Total Marrow Irradiation for Enhanced Dosimetric Conformality 60
NPM1 haploinsufficiency in MDS/AML with del(5q)/monosomy 5 59
Donor natural killer cells trigger production of beta-2-microglobulin to enhance post bone marrow transplant immunity 58
Venetoclax plus azacitidine as genetic-driven bridge-to-transplant therapy for IDH2-mutated acute myeloid leukaemia (AML) refractory to intensive chemotherapy: proof-of-concept case reports 58
Polatuzumab‐bendamustine‐rituximab as bridge to CD19‐directed CAR T cells in mantle cell lymphoma refractory to ibrutinib and venetoclax 58
The Use of Monoclonal Antibody Directed Chimeric Antigen Receptors to Facilitate Conventional T Cell and Treg Control of GvHD and Tissue Tolerance in Murine Models 57
TREG/TCON immunotherapy promotes HSC-derived B lymphopoiesis and boosts B cell immunity after haploidentical transplantation 56
Indirect Impact of PD-1/PD-L1 Blockade on a Murine Model of NK Cell Exhaustion 55
Host CD4+CD25+FoxP3+Regulatory T Cells Facilitate Donor Engraftment Without Impacting Graft Versus Host Disease Onset After Major-Mismatched Hematopoietic Stem Cell Transplantation 55
Venetoclax and Bortezomib in Relapsed/Refractory Early T-Cell Precursor Acute Lymphoblastic Leukemia 54
Total marrow irradiation reduces organ damage and enhances tissue repair with the potential to increase the targeted dose of bone marrow in both young and old mice 53
TNF-α priming enhances CD4+FoxP3+regulatory T-cell suppressive function in murine GVHD prevention and treatment 53
The Use of Monoclonal Antibody Directed Chimeric Antigen Receptors to Guide T Cell and Treg Homing for GvHD Control and Tissue Tolerance in Murine Models 52
TNF-Alpha Priming Enhances CD4(+) FoxP3(+) Regulatory T Cell Suppressive Function in GvHD Prevention and Treatment 51
Freeze and thaw of CD4+CD25+Foxp3+ regulatory T cells results in loss of CD62L expression and a reduced capacity to protect against graft-versus-host disease 50
NK Cell and CD4+FoxP3+ Regulatory T Cell Based Therapies for Hematopoietic Stem Cell Engraftment 49
Infusion of Host-Derived Unlicensed NK Cells Improves Donor Engraftment in Non-Myeloablative Allogeneic Hematopoietic Cell Transplantation 48
TIM-1 Blockade of the Donor Graft Provides Protection Against Lethal Gvhd 48
Regulatory T Cell Immunotherapy in Immune-Mediated Diseases 47
Third Party Invariant Natural Killer T Cells Protect from Lethal Graft-Versus-Host Disease through Donor CD4+CD25+FoxP3+ Regulatory T Cells 46
TIM-1 blockade of the donor graft provides protection against lethal GVHD 46
Editorial: The Immunobiology of HLA-Haploidentical Hematopoietic Cell Transplantation 45
First Multimodal, Three-Dimensional, Image-Guided Total Marrow Irradiation Model for Preclinical Bone Marrow Transplantation Studies 42
TNF-Alpha Priming Enhances CD4+FoxP3+ Regulatory T Cell Suppressive Function in GVHD Prevention and Treatment 42
Mast cells suppress murine GVHD in a mechanism independent of CD4+ CD25+ regulatory T cells 39
null 34
How adoptive transfer of components of the donor immune system boosts GvL and prevents GvHD in HLA-haploidentical hematopoietic transplantation for acute leukemia 33
Role of donor regulatory T cell adoptive immunotherapy in B cell immunity after hematopoietic cell transplantation 27
null 27
Third-party CD4+ invariant natural killer T cells protect from murine GVHD lethality 21
Safety of 20Gy Total Marrow Irradiation Based Conditioning Regimen for Hematopoietic Cell Transplantation with T Cell Adoptive Immunotherapy 17
A Combination of Plerixafor and Filgrasting Promotes Successful CD34+ Cell Collection for CRISPR/Cas9 Therapy in Sickle Cell Disease Patients With Insufficient Response to Plerixafor Alone 12
Totale 6.951
Categoria #
all - tutte 32.099
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 32.099


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202129 0 0 0 0 0 0 0 0 0 8 17 4
2021/2022654 9 199 1 15 29 7 10 175 11 25 101 72
2022/2023947 63 212 12 53 62 91 5 39 335 11 48 16
2023/2024584 15 59 14 14 2 14 118 8 41 26 127 146
2024/20251.339 41 126 49 59 176 86 72 101 237 77 196 119
2025/20262.849 220 215 157 404 403 251 520 167 286 226 0 0
Totale 6.951